Can Monocytopenia be a New Indicator in Determining Survival in Covid-19 Disease?

被引:4
作者
Pehlivan, Ozlem [1 ]
Serin, Sibel O. [2 ]
Yesil, Ezgi E. [3 ]
Demirdag, Filiz [4 ]
机构
[1] Univ Hlth Sci, Umraniye Training & Res Hosp, Dept Rheumatol, Istanbul, Turkey
[2] Univ Hlth Sci, Umraniye Training & Res Hosp, Dept Internal Med, Istanbul, Turkey
[3] Univ Hlth Sci, Umraniye Training & Res Hosp, Dept Nephrol, Istanbul, Turkey
[4] Univ Hlth Sci, Umraniye Training & Res Hosp, Dept Geriatr, Istanbul, Turkey
关键词
Covid-19; survival; monocytopenia; CLINICAL CHARACTERISTICS; CORONAVIRUS DISEASE;
D O I
10.7754/Clin.Lab.2021.210215
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Monocytes play a central role in Covid-19 infection. Monocytopenia is especially observed in patients with severe infection. In our study, we aimed to investigate the effects of monocytopenia on survival in patients presenting with the suspicion of Covid-19. Methods: Patients diagnosed with Covid-19 who received inpatient or outpatient treatment in the pandemic clinic of Umraniye Training and Research Hospital between April 2020 and July 2020 were included in our retrospective cohort study. Patients were divided into two groups, severe and non-severe. Demographic data, laboratory parameters, those who were monocytopenic at presentation, those who developed monocytopenia during follow-up, and those with persistent monocytopenia were noted. Results: The study included 471 patients with a mean age of 50.4 +/- 18.2 years. Sixty-seven (14.2%) patients had severe and 404 (85.8%) had non-severe disease. The minimum value of monocytes detected during the follow-up in severe patients was significantly lower (p < 0.001). As patients were grouped into those with monocytopenia at the time of admission, those with monocytopenia developing during their follow-up, and those whose monocytopenia at admission persisted, they were compared with regards to the presence or absence of severe disease. Newly developing monocytopenia and persistent monocytopenia were significant in patients with severe disease (p < 0.001, p = 0,001 respectively). Also, among non-surviving patients, there was a significant difference in survival times in the monocytopenia group (p = 0.029). Conclusions: In our study, we found more developing and persistent monocytopenia in the severe group, and the survival time was low, especially in those with newly developing monocytopenia. The development of monocytopenia in the daily hemogram follow-up of the patients may increase the possibility of mortality, which suggests that monocytopenia may be a new marker in determining survival.
引用
收藏
页码:2339 / 2346
页数:8
相关论文
共 24 条
  • [1] Comparative analysis of laboratory indexes of severe and non-severe patients infected with COVID-19
    Bao, Jinfeng
    Li, Chenxi
    Zhang, Kai
    Kang, Haiquan
    Chen, Wensen
    Gu, Bing
    [J]. CLINICA CHIMICA ACTA, 2020, 509 : 180 - 194
  • [2] Coronavirus Disease 2019 in Geriatrics and Long-Term Care: The ABCDs of COVID-19
    D'Adamo, Heather
    Yoshikawa, Thomas
    Ouslander, Joseph G.
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2020, 68 (05) : 912 - 917
  • [3] Dhama K, 2020, CLIN MICROBIOL REV, V33, DOI [10.1128/CMR.00028-20, 10.1038/s41432-020-0088-4]
  • [4] Routine blood tests as a potential diagnostic tool for COVID-19
    Ferrari, Davide
    Motta, Andrea
    Strollo, Marta
    Banfi, Giuseppe
    Locatelli, Massimo
    [J]. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2020, 58 (07) : 1095 - 1099
  • [5] Clinical Characteristics of Coronavirus Disease 2019 in China
    Guan, W.
    Ni, Z.
    Hu, Yu
    Liang, W.
    Ou, C.
    He, J.
    Liu, L.
    Shan, H.
    Lei, C.
    Hui, D. S. C.
    Du, B.
    Li, L.
    Zeng, G.
    Yuen, K. -Y.
    Chen, R.
    Tang, C.
    Wang, T.
    Chen, P.
    Xiang, J.
    Li, S.
    Wang, Jin-lin
    Liang, Z.
    Peng, Y.
    Wei, L.
    Liu, Y.
    Hu, Ya-hua
    Peng, P.
    Wang, Jian-ming
    Liu, J.
    Chen, Z.
    Li, G.
    Zheng, Z.
    Qiu, S.
    Luo, J.
    Ye, C.
    Zhu, S.
    Zhong, N.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (18) : 1708 - 1720
  • [6] Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis
    Henry, Brandon Michael
    de Oliveira, Maria Helena Santos
    Benoit, Stefanie
    Plebani, Mario
    Lippi, Giuseppe
    [J]. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2020, 58 (07) : 1021 - 1028
  • [7] Prognostic factors for severity and mortality in patients infected with COVID-19: A systematic review
    Izcovich, Ariel
    Alberto Ragusa, Martin
    Tortosa, Fernando
    Lavena Marzio, Maria Andrea
    Agnoletti, Camila
    Bengolea, Agustin
    Ceirano, Agustina
    Espinosa, Federico
    Saavedra, Ezequiel
    Sanguine, Veronica
    Tassara, Alfredo
    Cid, Candelaria
    Norberto Catalano, Hugo
    Agarwal, Arnav
    Foroutan, Farid
    Rada, Gabriel
    [J]. PLOS ONE, 2020, 15 (11):
  • [8] The Clinical and Chest CT Features Associated With Severe and Critical COVID-19 Pneumonia
    Li, Kunhua
    Wu, Jiong
    Wu, Faqi
    Guo, Dajing
    Chen, Linli
    Fang, Zheng
    Li, Chuanming
    [J]. INVESTIGATIVE RADIOLOGY, 2020, 55 (06) : 327 - 331
  • [9] Li LQ, 2020, J MED VIROL, V92, P577, DOI [10.1002/jmv.25757, 10.1016/j.jnlest.2020.100045]
  • [10] Li XM., 2000, Journal of Allergy and Clinical Immunology